,
your personalized virtual assistant to find clinical trials. Go head, 
Robert W. Veith
Mary Bird Perkins Cancer Center ...Baton Rouge, Louisiana - 70809 (225-767-0847) |
- CLINICAL TRIALS 24
- CONDITIONS38
- INTERVENTIONS38
- SINCE2003
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
June 2008 - December 2009
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012
Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
June 2010 - February 2013
Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013
Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor
December 2007 - January 2012
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011
Dinaciclib in Treating Patients With Stage IV Melanoma
July 2009 - May 2010
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
November 2007 - January 2014
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
March 2005 -
Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy
September 2009 - January 2012
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
December 2006 - September 2011
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
July 2006 - April 2024
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
May 2009 - July 2010
Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012
Cetuximab Cisplatin Fluorouracil and Radiation Therapy in Treating Patients With Stage I Stage II or Stage III Anal Cancer
January 2007 - July 2012
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
July 2009 - August 2011
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
March 2010 - January 2020
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
January 2004 - January 2008
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Neoplasm Metastasis
Urinary Bladder Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Fatigue
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Melanoma
Carcinoma, Small Cell
Neurotoxicity Syndromes
Precancerous Conditions
Colorectal Neoplasms
Carcinoma, Transitional Cell
Neuroendocrine Tumors
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Radiation Injuries
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Anus Neoplasms
Carcinoma, Ductal, Breast
Ureteral Neoplasms
Carcinoma, Ductal
Urologic Neoplasms
Carcinoma, Neuroendocrine
Urethral Neoplasms
Placebo
Zoledronic Acid
Celecoxib
Aflibercept
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Gemcitabine Hydrochloride
Cyclophosphamide
Radiation Therapy
Pemetrexed Disodium
3-Dimensional Conformal Radiation Therapy
Oxaliplatin
Doxorubicin Hydrochloride
Temsirolimus
Sunitinib Malate
Goserelin
Leuprolide Acetate
Trastuzumab
Sorafenib Tosylate
Rosuvastatin
Conventional Surgery
Cetuximab
Biologic Sample Preservation Procedure
Irinotecan Hydrochloride
Topotecan Hydrochloride
Ac Regimen
Vinorelbine Ditartrate
Placebo Administration
Recombinant Interferon Alfa-2b
Octreotide Acetate
Dinaciclib
Acetyl-L-Carnitine Hydrochloride
Antiandrogen Therapy
